According to a recent LinkedIn post from Latent, the company is featured as a technology partner in a case study involving Ochsner Health and its Chief Pharmacy Officer, Debbie Simonson. The post highlights workflow improvements in medication access and prior authorization processes achieved at Ochsner using Latent’s solutions.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post cites reported gains including a 127% increase in prior authorization throughput, a 67% reduction in review time, and an 89% reduction in appeal review time. If sustainable and reproducible at additional health systems, such performance metrics could enhance Latent’s value proposition in the healthcare automation and pharmacy workflow market.
The post also references Simonson’s participation in the Becker’s Healthcare CPO Summit, which may provide Latent with incremental visibility among senior pharmacy and health system executives. For investors, this suggests potential for expanded enterprise adoption and deeper integration into large health systems, which could support future revenue growth and competitive positioning.